Testing Hypotheses of Covariate-Adaptive Randomized Clinical Trials

被引:51
|
作者
Ma, We [1 ]
Hu, Feifang [2 ]
Zhang, Lixin [3 ]
机构
[1] Univ Virginia, Dept Stat, Charlottesville, VA 22904 USA
[2] George Washington Univ, Dept Stat, Washington, DC 20052 USA
[3] Zhejiang Univ, Dept Math, Hangzhou 310006, Zhejiang, Peoples R China
基金
美国国家科学基金会;
关键词
Conservative tests; Linear models; Pocock and Simon's marginal procedure; Power; Stratified permuted block design; Type I error; CELL LUNG-CANCER; ASYMPTOTIC PROPERTIES; GEMCITABINE PLUS; ALLOCATION; DESIGNS; STRATIFICATION; POWER;
D O I
10.1080/01621459.2014.922469
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Covariate-adaptive designs are often implemented to balance important covariates in clinical trials. However, the theoretical properties of conventional testing hypotheses are usually unknown under covariate-adaptive randomized clinical trials. In the literature, most studies are based on simulations. In this article, we provide theoretical foundation of hypothesis testing under covariate-adaptive designs based on linear models. We derive the asymptotic distributions of the test statistics of testing both treatment effects and the significance of covariates under null and alternative hypotheses. Under a large class of covariate-adaptive designs, (i) the hypothesis testing to compare treatment effects is usually conservative in terms of small Type I error; (ii) the hypothesis testing to compare treatment effects is usually more powerful than complete randomization; and (iii) the hypothesis testing for significance of covariates is still valid. The class includes most of the covariate-adaptive designs in the literature; for example, Pocock and Simon's marginal procedure, stratified permuted block design, etc. Numerical studies are also performed to assess their corresponding finite sample properties. Supplementary material for this article is available online.
引用
收藏
页码:669 / 680
页数:12
相关论文
共 50 条
  • [1] SEQUENTIAL MONITORING OF COVARIATE-ADAPTIVE RANDOMIZED CLINICAL TRIALS
    Zhu, Hongjian
    Hu, Feifang
    STATISTICA SINICA, 2019, 29 (01) : 265 - 282
  • [2] The impact of misclassification on covariate-adaptive randomized clinical trials
    Wang, Tong
    Ma, Wei
    BIOMETRICS, 2021, 77 (02) : 451 - 464
  • [3] A theory for testing hypotheses under covariate-adaptive randomization
    Shao, Jun
    Yu, Xinxin
    Zhong, Bob
    BIOMETRIKA, 2010, 97 (02) : 347 - 360
  • [4] Covariate-Adaptive Optimization in Online Clinical Trials
    Bertsimas, Dimitris
    Korolko, Nikita
    Weinstein, Alexander M.
    OPERATIONS RESEARCH, 2019, 67 (04) : 1150 - 1161
  • [5] The impact of misclassification on covariate-adaptive randomized clinical trials with generalized linear models
    Wang, Tong
    Ma, Wei
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2025, 234
  • [6] Covariate-adaptive designs with missing covariates in clinical trials
    LIU ZhongQiang
    YIN JianXin
    HU FeiFang
    Science China(Mathematics), 2015, 58 (06) : 1191 - 1202
  • [7] Sample size re-estimation for covariate-adaptive randomized clinical trials
    Li, Xin
    Ma, Wei
    Hu, Feifang
    STATISTICS IN MEDICINE, 2021, 40 (12) : 2839 - 2858
  • [8] Covariate-adaptive designs with missing covariates in clinical trials
    Liu ZhongQiang
    Yin JianXin
    Hu FeiFang
    SCIENCE CHINA-MATHEMATICS, 2015, 58 (06) : 1191 - 1202
  • [9] Covariate-adaptive designs with missing covariates in clinical trials
    ZhongQiang Liu
    JianXin Yin
    FeiFang Hu
    Science China Mathematics, 2015, 58 : 1191 - 1202
  • [10] Covariate-adaptive randomization with variable selection in clinical trials
    Zhang, Hao
    Hu, Feifang
    Yin, Jianxin
    STAT, 2022, 11 (01):